106 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
these values continue to guide us in creating sustainable value for society and our stakeholders, and improved healthcare for patients around the world. Takeda … ") Initiative for sustainable value creation in the areas of healthcare, workforce management, environmental impact, and business governance. This report has
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
patients, healthcare professionals, employees, clients such as suppliers and vendors, creditors and local communities in order to strengthen long … therapeutic areas. He has also served in several key positions at global pharmaceutical and healthcare companies in the U.S. and Europe. He has deep insights
6-K
TAK
Takeda Pharmaceutical Co
11 Jul 22
Current report (foreign)
6:05am
the interests of not only shareholders, but various stakeholders including patients, healthcare professionals, employees, clients such as suppliers … areas. He has also served in several key positions at global healthcare companies in the U.S. and Europe. He has deep insights gained from his extensive
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
, healthcare professionals, employees, clients such as suppliers and vendors, creditors and local communities in order to strengthen long- term … at global pharmaceutical and healthcare companies in the U.S. and Europe. He has deep insights gained from his extensive experience in the management
6-K
TAK
Takeda Pharmaceutical Co
1 Nov 21
Current report (foreign)
6:04am
other than Shareholders
The Company takes into account the interests of various stakeholders including patients, healthcare professionals, employees … expertise in Shire's portfolio and its related therapeutic areas. He also held various key positions in global healthcare companies in Europe and the U.S
6-K
i9wo4wziqnpwqo2
24 Aug 20
from 6-K
6:04am
6-K
bltp8v4p54e917
31 Mar 21
Current report (foreign)
6:09am
6-K
e1t 3doabu089f
29 Jul 20
Current report (foreign)
6:07am
6-K
v91f8 teholb
19 Jul 21
Current report (foreign)
6:02am
6-K
2p2aaa 60n7
14 Jan 20
Current report (foreign)
6:56am
6-K
28cn1t wwzrvvrk2sp2
16 Jul 19
Current report (foreign)
8:50am
6-K
gh93kz3164ab
11 Jan 22
Current report (foreign)
6:04am
6-K
5p8srt dpb7ljub
14 Jun 19
Current report (foreign)
6:17am
6-K
4nlw3rix
31 Jan 19
Current report (foreign)
6:07am
6-K
EX-99.1
bvdfoby9lcnp jrws7
31 May 22
Current report (foreign)
12:00am
6-K
EX-99.1
dwb432hmfe6mt
31 May 22
Current report (foreign)
6:07am
UPLOAD
3x7 78aefa
15 Aug 19
Letter from SEC
12:00am
6-K
EX-99.1
38m4ysbutk
28 May 21
Current report (foreign)
6:01am
6-K
EX-99.1
qkk5d d8v8
30 May 23
Current report (foreign)
6:11am
6-K
EX-99.1
z9jvue
23 Jun 23
Current report (foreign)
6:13am